Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection

Covid-19 is a new coronavirus disease first described in December 2019. This respiratory illness is severe and potentially fatal. Severe cases make up to 15%, lethality ranges between 1.5 and more than 10%. What is urgently needed is an efficient pharmacological treatment for the treatment of severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Klimke, A., Hefner, G., Will, B., Voss, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185016/
https://www.ncbi.nlm.nih.gov/pubmed/32402766
http://dx.doi.org/10.1016/j.mehy.2020.109783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185016/
https://www.ncbi.nlm.nih.gov/pubmed/32402766
http://dx.doi.org/10.1016/j.mehy.2020.109783

Ejemplares similares